The news: Walmart is expanding its recently launched digital health platform to include a marketplace for obesity and weight management aimed at customers using or considering GLP-1 therapies.

Walmart’s “Better Care Services” launched in January with a network of third-party telehealth partners and discounted health and wellness products. The expansion adds obesity-focused services through partnerships with five providers spanning GLP-1 use around fitness, nutrition, coaching, telehealth, and personalized insights.

Why it matters: Walmart’s move into obesity and weight management services comes as Medicare prepares to cover GLP-1 prescriptions at a low monthly cost, opening the door to a potential surge of older patients.

• Medicare will cover weight loss drugs—including Novo Nordisk’s Wegovy (injection and pill) and Eli Lilly’s Zepbound and Foundayo—starting in July for a flat $50 monthly copay under a gap program until full coverage for seniors begins in January.
• Walmart captures 17% of baby boomers (ages 62-80) total annual spending, per Numerator, above the national average of 15%. That’s also well ahead of the next most-used retailers by boomers—Amazon (9%) and Costco (5%).
• About 10% of the 66 million Medicare beneficiaries are expected to be eligible for GLP-1 drugs, including those who are overweight or obese or have another covered condition such as diabetes.

Implications for retail pharmacies and GLP-1 drugmakers: For older GLP-1 patients, Walmart’s combination of everyday convenience and obesity support services offers an easy on-ramp to treatment where they’re already shopping. This raises the stakes for retailers to move beyond dispensing prescriptions to offering broader weight management support services.

For drugmakers, the shift brings obesity treatment further into mainstream retail, making big-box players more important partners for patient adherence, engagement, and long-term outcomes—not just prescription volume.

This content is part of EMARKETER’s subscription Briefings, where we pair daily updates with data and analysis from forecasts and research reports. Our Briefings prepare you to start your day informed, to provide critical insights in an important meeting, and to understand the context of what’s happening in your industry. Not a subscriber? Click here to get a demo of our full platform and coverage.